Telix Pharmaceuticals Limited (TLPPF) Net margin 2023–2025
Telix Pharmaceuticals Limited (TLPPF) net profit margin by fiscal year — reported net income divided by reported revenue.
-0.9%FY2025 · since FY2023: 1.3% → -0.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.9% | -7.4 pp |
| FY2024 | 6.5% | +5.3 pp |
| FY2023 | 1.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating marginTLPPF Operating cash flowTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →